4//SEC Filing
Rousseau Raphael 4
Accession 0001567619-19-017520
CIK 0001656634other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:08 PM ET
Size
8.7 KB
Accession
0001567619-19-017520
Insider Transaction Report
Form 4
Rousseau Raphael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2019-08-21$0.76/sh+10,000$7,600→ 10,000 total - Sale
Common Stock
2019-08-21$10.76/sh−10,000$107,631→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-21−10,000→ 155,326 totalExercise: $0.76From: 2018-04-17Exp: 2027-05-17→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $10.71 to $10.87 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F2]The stock option vests and becomes exercisable with respect to 25% of the total number of shares on April 17, 2018. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
Related Parties
1- filerCIK 0001754287
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:08 PM ET
- Size
- 8.7 KB